The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Agenus Inc | COM | 00847G705 | 7,854,611 | 4,909,132 | SH | SOLE | 4,909,132 | 0 | 0 | |||
Allakos Inc | COM | 01671P100 | 272,347 | 62,465 | SH | SOLE | 62,465 | 0 | 0 | |||
AstraZeneca PLC | SPONSORED ADR | 046353108 | 121,491,292 | 1,697,517 | SH | SOLE | 1,697,517 | 0 | 0 | |||
Axsome Therapeutics Inc | COM | 05464T104 | 12,880,330 | 179,242 | SH | SOLE | 179,242 | 0 | 0 | |||
Baxter Intl Inc | COM | 071813109 | 16,501,832 | 362,200 | SH | SOLE | 362,200 | 0 | 0 | |||
Boston Scientific Corp | COM | 101137107 | 32,933,291 | 608,861 | SH | SOLE | 608,861 | 0 | 0 | |||
Celldex Therapeutics Inc | COM | 15117B202 | 6,709,929 | 197,758 | SH | SOLE | 197,758 | 0 | 0 | |||
Cytokinetics Inc | COM | 23282W605 | 27,506,097 | 843,228 | SH | SOLE | 843,228 | 0 | 0 | |||
Dexcom Inc | COM | 252131107 | 47,641,227 | 370,720 | SH | SOLE | 370,720 | 0 | 0 | |||
Dyne Therapeutics Inc | COM | 26818M108 | 4,961,790 | 441,048 | SH | SOLE | 441,048 | 0 | 0 | |||
Exelixis Inc | COM | 30161Q104 | 48,935,703 | 2,560,738 | SH | SOLE | 2,560,738 | 0 | 0 | |||
FibroGen Inc | COM | 31572Q808 | 675,000 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | ||
FibroGen Inc | COM | 31572Q808 | 1,721,431 | 637,567 | SH | SOLE | 637,567 | 0 | 0 | |||
FibroGen Inc | COM | 31572Q808 | 405,000 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | ||
FibroGen Inc | COM | 31572Q808 | 675,000 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | ||
FibroGen Inc | COM | 31572Q808 | 675,000 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | ||
Geron Corp | COM | 374163103 | 17,427,588 | 5,429,155 | SH | SOLE | 5,429,155 | 0 | 0 | |||
IDEAYA Biosciences Inc | COM | 45166A102 | 15,621,531 | 664,746 | SH | SOLE | 664,746 | 0 | 0 | |||
IDEXX Laboratories Inc | COM | 45168D104 | 35,494,603 | 70,674 | SH | SOLE | 70,674 | 0 | 0 | |||
Immatics NV | SHS | N44445109 | 35,098,760 | 3,041,487 | SH | SOLE | 3,041,487 | 0 | 0 | |||
ImmunoGen Inc | COM | 45253H101 | 15,611,491 | 827,318 | SH | SOLE | 827,318 | 0 | 0 | |||
Inhibrx Inc | COM | 45720L107 | 25,915,427 | 998,283 | SH | SOLE | 998,283 | 0 | 0 | |||
Intuitive Surgical Inc | COM | 46120E602 | 68,792,173 | 201,182 | SH | SOLE | 201,182 | 0 | 0 | |||
Karuna Therapeutics Inc | COM | 48576A100 | 148,109 | 683 | SH | SOLE | 683 | 0 | 0 | |||
Marinus Pharmaceuticals Inc | COM | 56854Q200 | 2,172,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | ||
Marinus Pharmaceuticals Inc | COM | 56854Q200 | 10,454,042 | 962,619 | SH | SOLE | 962,619 | 0 | 0 | |||
Merck & Co Inc | COM | 58933Y105 | 60,853,570 | 527,373 | SH | SOLE | 527,373 | 0 | 0 | |||
Mirum Pharmaceuticals Inc | COM | 604749101 | 235,132 | 9,089 | SH | SOLE | 9,089 | 0 | 0 | |||
PTC Therapeutics Inc | COM | 69366J200 | 10,592,217 | 260,443 | SH | SOLE | 260,443 | 0 | 0 | |||
Reata Pharmaceuticals Inc | CL A | 75615P103 | 32,879,143 | 322,471 | SH | SOLE | 322,471 | 0 | 0 | |||
Replimune Group Inc | COM | 76029N106 | 8,101,203 | 348,889 | SH | SOLE | 348,889 | 0 | 0 | |||
Revolution Medicines Inc | COM | 76155X100 | 13,920,085 | 520,377 | SH | SOLE | 520,377 | 0 | 0 | |||
Savara Inc | COM | 805111101 | 307,512 | 96,248 | SH | SOLE | 96,248 | 0 | 0 | |||
Spruce Biosciences Inc | COM | 85209E109 | 124,762 | 58,029 | SH | SOLE | 58,029 | 0 | 0 | |||
Syndax Pharmaceuticals Inc | COM | 87164F105 | 33,117,351 | 1,582,291 | SH | SOLE | 1,582,291 | 0 | 0 | |||
Vertex Pharmaceuticals Inc | COM | 92532F100 | 51,132,523 | 145,300 | SH | SOLE | 145,300 | 0 | 0 | |||
Vir Biotechnology Inc | COM | 92764N102 | 7,359,000 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | ||
Vir Biotechnology Inc | COM | 92764N102 | 11,973,510 | 488,117 | SH | SOLE | 488,117 | 0 | 0 | |||
Zentalis Pharmaceuticals Inc | COM | 98943L107 | 23,358,021 | 828,005 | SH | SOLE | 828,005 | 0 | 0 | |||
argenx SE | SPONSORED ADR | 04016X101 | 15,558,411 | 39,921 | SH | SOLE | 39,921 | 0 | 0 | |||
Aerovate Therapeutics Inc | COM | 008064107 | 64,461,465 | 3,758,686 | SH | SOLE | 3,758,686 | 0 | 0 | |||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 67,297,356 | 754,032 | SH | SOLE | 754,032 | 0 | 0 | |||
Bolt Biotherapeutics Inc | COM | 097702104 | 3,525,679 | 2,754,437 | SH | SOLE | 2,754,437 | 0 | 0 | |||
Fusion Pharmaceuticals Inc | COM | 36118A100 | 546,852 | 117,099 | SH | SOLE | 117,099 | 0 | 0 | |||
Galera Therapeutics Inc | COM | 36338D108 | 9,621,181 | 3,083,712 | SH | SOLE | 3,083,712 | 0 | 0 | |||
Inozyme Pharma Inc | COM | 45790W108 | 20,360,066 | 3,655,308 | SH | SOLE | 3,655,308 | 0 | 0 | |||
Karuna Therapeutics Inc | COM | 48576A100 | 299,354,052 | 1,380,466 | SH | SOLE | 1,380,466 | 0 | 0 | |||
Natera Inc | COM | 632307104 | 150,873,250 | 3,100,560 | SH | SOLE | 3,100,560 | 0 | 0 | |||
Nextcure Inc | COM | 65343E108 | 4,809,341 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | |||
Nucana PLC | SPONSORED ADR | 67022C106 | 4,423,999 | 5,599,999 | SH | SOLE | 5,599,999 | 0 | 0 | |||
Nucana PLC | COMMON SHARES | GB00BYWYV | 1,896,000 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | |||
PDS Biotechnology Corp | COM | 70465T107 | 717,454 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | |||
Synlogic Inc | COM | 87166L100 | 247,238 | 574,972 | SH | SOLE | 574,972 | 0 | 0 | |||
Vera Therapeutics Inc | CL A | 92337R101 | 55,647,854 | 3,467,156 | SH | SOLE | 3,467,156 | 0 | 0 | |||
Y-mAbs Therapeutics Inc | COM | 984241109 | 14,899,148 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 |